Potential clinical utility of a novel, long-acting bisphosphonate in metabolic bone disease

被引：0

作者：

Reid, I. R. ^{[1
]}

机构：

[1] Univ Auckland, Dept Med, Auckland 1, New Zealand

来源：

OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S118 / S119

页数：2

共 50 条

[1] Efficacy of long-acting bisphosphonates in metabolic bone diseases
Adachi, J.
OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S359 - S360
[2] NOVEL, LONG-ACTING AND SELECTIVE PHYSOSTIGMINE ANALOGS AS POTENTIAL THERAPEUTICS FOR ALZHEIMERS-DISEASE
GREIG, NH
BROSSI, A
SONCRANT, TT
HOLLOWAY, HW
PEI, XF
RAPOPORT, SI
INGRAM, DK
JOURNAL OF CONTROLLED RELEASE, 1994, 28 (1-3) : 313 - 313
[3] METABOLIC STUDIES WITH LONG-ACTING COMPOUNDS
SCHREIBER, EC
GROZIER, ML
THERAPIE, 1973, 28 (03): : 441 - 449
[4] Long-acting erythropoietin: clinical studies and potential uses in neonates
Ohls, RK
Dai, AH
CLINICS IN PERINATOLOGY, 2004, 31 (01) : 77 - +
[5] Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol
Matera, Maria Gabriella
Ora, Josuel
Cazzola, Mario
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1805 - 1811
[6] CONSIDERATIONS OF METABOLIC STUDIES OF LONG-ACTING DRUGS
SCHREIBER, EC
PSYCHOPHARMACOLOGIA, 1972, 26 : 103 - +
[7] METABOLIC EFFECTS OF LONG-ACTING EPINEPHRINE IN SHEEP
GANS, JH
BIGGS, DL
AMERICAN JOURNAL OF VETERINARY RESEARCH, 1968, 29 (06) : 1167 - &
[8] DIFLUNISAL - NOVEL LONG-ACTING ANALGESIC
BAHOUS, I
LUTTERBECK, PM
TEMPERO, KF
CLINICAL THERAPEUTICS, 1978, 1 : 10 - 19
[9] Clinical Efficacy of Long-Acting β2 Agonists and Long-Acting Muscarinic Antagonist for Moderate to Severe Chronic Obstructive Pulmonary Disease
Yongqian Xu
Yu Pang
Pharmaceutical Chemistry Journal, 2023, 57 : 365 - 372
[10] Novel Long-Acting GH Preparations
Doknic, Mirjana
Stojanovic, Marko
Popovic, Vera
PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2014, 12 (02) : 206 - 212

← 1 2 3 4 5 →